For: | McFarland LV. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World J Gastroenterol 2008; 14(17): 2625-2629 [PMID: 18461647 DOI: 10.3748/wjg.14.2625] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i17/2625.htm |
Number | Citing Articles |
1 |
Graeme Tobyn, Alison Denham, Margaret Whitelegg. Medical Herbs. 2011; : 241 doi: 10.1016/B978-0-443-10344-5.00029-X
|
2 |
Florent Amsallem, Stéphane Sanchez, Xavier Armoiry, François Mion, Samuel Martins Silvestre. Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/4404185
|
3 |
Arvind I. Srinath, Susan A. Turner, Eva Szigethy. Functional Symptoms in Pediatric Disease. 2014; : 59 doi: 10.1007/978-1-4899-8074-8_5
|
4 |
Bozong Tang, Jianliang Zhang, Zongguo Yang, Yunfei Lu, Qingnian Xu, Xiaorong Chen, Jiang Lin, Jiande D. Z. Chen. Moxibustion for Diarrhea‐Predominant Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/5105108
|
5 |
Kathryn M. Carbone. Sequelae and Long-Term Consequences of Infectious Diseases. 2014; : 1 doi: 10.1128/9781555815486.ch1
|
6 |
Feride Oeztuerk-Winder, Juan-Jose Ventura. The many faces of p38 mitogen-activated protein kinase in progenitor/stem cell differentiation. Biochemical Journal 2012; 445(1): 1 doi: 10.1042/BJ20120401
|
7 |
Gordon V. Ohning. Intestinal Mucins. Journal of Clinical Gastroenterology 2013; 47(2): 104 doi: 10.1097/MCG.0b013e3182713185
|
8 |
Ananda Chandrasekara, Geeshani Somaratne. Industrial Application of Functional Foods, Ingredients and Nutraceuticals. 2023; : 501 doi: 10.1016/B978-0-12-824312-1.00015-7
|
9 |
Jan-Hendrik Egberts, Antje Stroeh, Ibrahim Alkatout, Freya A. Goumas, Phillipp A. Brand, Clemens Schafmayer, Thomas Becker, Bodo Schniewind. Preoperative risk evaluation of postoperative morbidity in IBD patients—impact of the POSSUM score. International Journal of Colorectal Disease 2011; 26(6): 783 doi: 10.1007/s00384-011-1179-7
|
10 |
Hye In Kim, Sung-Ae Jung, Ju Young Choi, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim, Kwon Yoo. Impact of Shiftwork on Irritable Bowel Syndrome and Functional Dyspepsia. Journal of Korean Medical Science 2013; 28(3): 431 doi: 10.3346/jkms.2013.28.3.431
|
11 |
Xiao-xiang Wang, Rui-jie Luo, Bin She, Yan Chen, Jia Guo. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial. Trials 2014; 15(1) doi: 10.1186/1745-6215-15-273
|
12 |
Haizhen Zheng, Rixin Chen, Xiaofeng Zhao, Guanhui Li, Yi Liang, Hao Zhang, Zhenhai Chi. Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis. Pain Research and Management 2019; 2019: 1 doi: 10.1155/2019/2871505
|
13 |
Arvind I. Srinath, Susan A. Turner, Eva Szigethy. Functional Symptoms in Pediatric Disease. 2014; : 59 doi: 10.1007/978-1-4899-8074-8_5
|
14 |
Jing Wu, Qinwei Fu, Shasha Yang, Hui Wang, Yaofeng Li, Tarique Hussain. Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea‐Predominant Irritable Bowel Syndrome and Constipation‐Predominant Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/5812320
|
15 |
Ashlee B. Carter, Sarah A. Misyak, Raquel Hontecillas, Josep Bassaganya-Riera, Rosa Canuto. Dietary Modulation of Inflammation‐Induced Colorectal Cancer through PPARγ. PPAR Research 2009; 2009(1) doi: 10.1155/2009/498352
|
16 |
O J Broom, B Widjaya, J Troelsen, J Olsen, O H Nielsen. Mitogen activated protein kinases: a role in inflammatory bowel disease?. Clinical and Experimental Immunology 2009; 158(3): 272 doi: 10.1111/j.1365-2249.2009.04033.x
|
17 |
Deepak K. Kadayakkara, Pamela L. Beatty, Michael S. Turner, Jelena M. Janjic, Eric T. Ahrens, Olivera J. Finn. Inflammation Driven by Overexpression of the Hypoglycosylated Abnormal Mucin 1 (MUC1) Links Inflammatory Bowel Disease and Pancreatitis. Pancreas 2010; 39(4): 510 doi: 10.1097/MPA.0b013e3181bd6501
|
18 |
M. Baranska, R. Trzcinski, A. Dziki, M. Rychlik-Sych, M. Dudarewicz, J. Skretkowicz. The Role of N-Acetyltransferase 2 Polymorphism in the Etiopathogenesis of Inflammatory Bowel Disease. Digestive Diseases and Sciences 2011; 56(7): 2073 doi: 10.1007/s10620-010-1527-4
|
19 |
Petra von Stein. Inflammatory bowel disease classification through multigene analysis: fact or fiction?. Expert Review of Molecular Diagnostics 2009; 9(1): 7 doi: 10.1586/14737159.9.1.7
|
20 |
Marika Mikelsaar, Veronica Lazar, Andrew Onderdonk, Gilanfranco Donelli. Do probiotic preparations for humans really have efficacy?. Microbial Ecology in Health and Disease 2011; 22(1): 10128 doi: 10.3402/mehd.v22i0.10128
|